سعر ميترونيدازول -المهن 250مجم 20 قرص 2024

Metronidazole 250 mg film-coated tablets (Medical Union Pharmaceuticals, MUP); pack of 20 tablets (2 strips).

• Symptomatic and asymptomatic trichomoniasis (and treatment of asymptomatic sexual partners).Population: AdultsDailyMed (U.S. NLM)
• Acute intestinal amebiasis (amebic dysentery) and amebic liver abscess.Population: Adults and childrenDailyMed (U.S. NLM)
• Serious anaerobic bacterial infections (often after initial IV therapy).Population: AdultsDailyMed (U.S. NLM)

• Common reactions include nausea, metallic taste, headache, anorexia and other GI effects; CNS effects, neutropenia and QT prolongation have been reported.International label, equivalent formulation · DailyMed (U.S. NLM)

• Hypersensitivity to metronidazole or other nitroimidazoles; first trimester of pregnancy in trichomoniasis.International label, equivalent formulation · DailyMed (U.S. NLM)
• Disulfiram within the last 2 weeks; alcohol or propylene glycol during and for at least 3 days after therapy; Cockayne syndrome.International label, equivalent formulation · DailyMed (U.S. NLM)

• Boxed warning: carcinogenic in mice and rats; avoid unnecessary use.International label, equivalent formulation · DailyMed (U.S. NLM)
• Encephalopathy, peripheral neuropathy, seizures and aseptic meningitis have been reported; severe cutaneous adverse reactions (SJS/TEN, DRESS, AGEP) reported.International label, equivalent formulation · DailyMed (U.S. NLM)

• WarfarinPotentiates the anticoagulant effect; monitor prothrombin time/INR.DailyMed (U.S. NLM)
• LithiumMay raise serum lithium; monitor lithium and creatinine.DailyMed (U.S. NLM)
• BusulfanIncreases busulfan concentrations and serious toxicity; avoid unless benefit outweighs risk.DailyMed (U.S. NLM)

• No adequate and well-controlled studies in pregnant women; data on more than 5000 exposed pregnancies (many first-trimester) did not consistently show increased congenital anomalies; one unconfirmed cleft-lip signal.International label, equivalent formulation · DailyMed (U.S. NLM)
• Present in human milk at concentrations similar to maternal serum; weigh breastfeeding benefits against risk, or pump and discard milk during therapy and for 24 hours after.International label, equivalent formulation · DailyMed (U.S. NLM)

• Metronidazole: Reduced inside susceptible anaerobes and protozoa to short-lived reactive intermediates that damage DNA, inhibiting nucleic acid synthesis and causing cell death.